Your browser doesn't support javascript.
loading
Expression, mutation, and methylation of cereblon-pathway genes at pre- and post-lenalidomide treatment in multiple myeloma.
Tachita, Takuto; Kinoshita, Shiori; Ri, Masaki; Aoki, Sho; Asano, Arisa; Kanamori, Takashi; Yoshida, Takashi; Totani, Haruhito; Ito, Asahi; Kusumoto, Shigeru; Komatsu, Hirokazu; Yamagata, Kazufumi; Kubo, Kohmei; Tohkin, Masahiro; Fukuda, Shinsaku; Iida, Shinsuke.
Affiliation
  • Tachita T; Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
  • Kinoshita S; Department of Gastroenterology and Hematology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
  • Ri M; Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
  • Aoki S; Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
  • Asano A; Department of Blood Transfusion and Cell Therapy, Nagoya City University Hospital, Nagoya, Japan.
  • Kanamori T; Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
  • Yoshida T; Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
  • Totani H; Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
  • Ito A; Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
  • Kusumoto S; Department of Clinical Oncology, Nagoya Memorial Hospital, Nagoya, Japan.
  • Komatsu H; Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
  • Yamagata K; Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
  • Kubo K; Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
  • Tohkin M; Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
  • Fukuda S; Department of Gastroenterology and Hematology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
  • Iida S; Department of Hematology, Aomori Prefectural Central Hospital, Aomori, Japan.
Cancer Sci ; 111(4): 1333-1343, 2020 Apr.
Article in En | MEDLINE | ID: mdl-32061138

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Alpha Karyopherins / Adaptor Proteins, Signal Transducing / Ikaros Transcription Factor / Lenalidomide / Multiple Myeloma Type of study: Prognostic_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Cancer Sci Year: 2020 Type: Article Affiliation country: Japan

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Alpha Karyopherins / Adaptor Proteins, Signal Transducing / Ikaros Transcription Factor / Lenalidomide / Multiple Myeloma Type of study: Prognostic_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Cancer Sci Year: 2020 Type: Article Affiliation country: Japan